Non steroidal anti-inflammatory drug-based pain control for minimally invasive direct coronary artery bypass surgery.
Minimally invasive direct coronary artery bypass (MIDCAB) surgery has become an attractive alternative technique to treat coronary artery insufficiency. Changes in surgical and anesthesia techniques have led to reduced pulmonary morbidity associated with the operation. Early extubation is typically expected. However, postoperative pain management becomes even more important with early extubation. We describe our technique of a NSAID-based protocol with indomethicin and Torodal that has been safe and effective in over 175 patients following MIDCAB.
Department of Cardiothoracic Surgery, Allegheny University Hospitals, Allegheny General, Pittsburgh, PA, USA.
J C
JC
Lin
M F
MF
Szwerc
J A
JA
Magovern
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002985:Clinical Protocols; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D020911:Ketorolac Tromethamine / Q000627:therapeutic use*; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects*; D010147:Pain Measurement; D010149:Postoperative Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D012449:Safety; D013997:Time Factors; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D020911:Ketorolac Tromethamine; D007213:Indomethacin